[go: up one dir, main page]

UA94938C2 - Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты) - Google Patents

Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты)

Info

Publication number
UA94938C2
UA94938C2 UAA200812737A UAA200812737A UA94938C2 UA 94938 C2 UA94938 C2 UA 94938C2 UA A200812737 A UAA200812737 A UA A200812737A UA A200812737 A UAA200812737 A UA A200812737A UA 94938 C2 UA94938 C2 UA 94938C2
Authority
UA
Ukraine
Prior art keywords
akaftadine
pharmaceutically acceptable
acceptable salt
treating
clinical symptom
Prior art date
Application number
UAA200812737A
Other languages
English (en)
Ukrainian (uk)
Inventor
Джагдиш Парасрампуриа
Авнер Ингерман
Франс Янссенс
Антон Мегенс
Original Assignee
ВИСТЕКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ВИСТЕКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи filed Critical ВИСТЕКОН ФАРМАСЬЮТИКАЛС, ЭлЭлСи
Publication of UA94938C2 publication Critical patent/UA94938C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к офтальмической композиции для лечения или предупреждения аллергических заболеваний и воспаления глаз и их симптомов, содержащей алкафтадин или его фармацевтически приемлемую соль.
UAA200812737A 2006-03-31 2007-03-26 Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты) UA94938C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78818506P 2006-03-31 2006-03-31

Publications (1)

Publication Number Publication Date
UA94938C2 true UA94938C2 (ru) 2011-06-25

Family

ID=40770601

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812737A UA94938C2 (ru) 2006-03-31 2007-03-26 Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты)

Country Status (3)

Country Link
CN (1) CN101460176B (ru)
AR (1) AR111697A2 (ru)
UA (1) UA94938C2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112724149A (zh) * 2016-06-07 2021-04-30 深圳市塔吉瑞生物医药有限公司 一种取代的稠合咪唑环化合物及其药物组合物
CN107854470B (zh) * 2016-09-21 2020-03-27 武汉武药科技有限公司 阿卡他定组合物、其制备方法和用途
EP3915539A1 (en) * 2018-01-18 2021-12-01 Faes Farma, S.A. Ophthalmic compositions comprising bilastine, a beta-cyclodextrin and at least one gelling agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions

Also Published As

Publication number Publication date
CN101460176A (zh) 2009-06-17
CN101460176B (zh) 2012-11-28
AR111697A2 (es) 2019-08-07

Similar Documents

Publication Publication Date Title
SG170044A1 (en) Ocular allergy treatments
WO2008029276A3 (en) Compositions and methods for the treatment of ophthalmic disease
PT1854477T (pt) Inibidores peptidicos da calicreína plasmática e sua utilização no tratamento de doenças oftalmológicas
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
WO2007143600A3 (en) Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
WO2009085271A3 (en) Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions
MX2008014515A (es) Suspension oftalmica para uso ocular.
WO2008013984A3 (en) Compositions and methods for treating or preventing ophthalmic disease
WO2007140317A3 (en) Use of inhibitors of cytosolic ph0sph0lipase a2 in the treatment of thrombosis
WO2011076368A3 (en) Topical ophthalmic peptide formulation
EP2005194A4 (en) HEMOGLOBIN-BASED METHODS FOR PROPHYLAXIS, DIAGNOSTIC OR BZW. TREATMENT OF NETWORK DISEASES
UA94938C2 (ru) Офтальмическая композиция для лечения клинических симптомов глазной аллергии, которая содержит алкафтадин или его производное (варианты)
EP2716285A3 (en) New method for identifying compounds useful for treating and/or preventing diseases associated with bone loss
WO2007108004A8 (en) S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
GB0523961D0 (en) The treatment of ophthalmic diseases
WO2010107991A3 (en) Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
WO2008067056A3 (en) Method of inhibiting coagulation with human anti-factor va antibodies and use thereof
WO2006078336A3 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
SI1854477T1 (sl) Peptidi, ki inhibirajo plazma kalikrein za uporabo pri zdravljenju očesnih motenj
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders
WO2008063559A3 (en) Methods for using optical agents
MX2009008734A (es) Gamma lactamas para el tratamiento de glaucoma o hipertension intraocular.
GB0523962D0 (en) The treatment of ophthalmic diseases
GB0523965D0 (en) The treatment of ophthalmic diseases